Published • loading... • Updated
FDA Approves AstraZeneca Lupus Autoinjector Treatment
Summary by MyChesCo
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
FDA Approves AstraZeneca Lupus Autoinjector Treatment
WILMINGTON, DE — AstraZeneca said the SAPHNELO Pen has received approval from the U.S. Food and Drug Administration for self-administration in adults with systemic lupus erythematosus receiving standard therapy. The once-weekly autoinjector allows subcutaneous administration of the lupus treatment outside clinical infusion settings. The approval was based on results from the Phase III TULIP-SC clinical trial, which showed statistically significa…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
